TY - JOUR
AU - Tacão, Marta
AU - Tavares, Rafael dos Santos
AU - Teixeira, Pedro
AU - Roxo, Inês
AU - Ramalheira, Elmano
AU - Ferreira, Sónia
AU - Henriques, Isabel
T1 - mcr-1 and blaKPC-3 in Escherichia coli Sequence Type 744 after Meropenem and Colistin Therapy, Portugal
T2 - Emerging Infectious Disease journal
PY - 2017
VL - 23
IS - 8
SP - 1419
SN - 1080-6059
AB - Escherichia coli Ec36 was recovered from a patient in Portugal after treatment with meropenem and colistin. Besides an IncF plasmid with Tn1441d-blaKPC-3, already reported in clinical strains in this country, E. coli Ec36 co-harbored an IncX4::mcr-1 gene. Results highlight emerging co-resistance to carbapenems and polymyxins after therapy with drugs from both classes.
KW - Gene, carbapenem, meropenem, colistin, polymixin
KW - fluconazole
KW - linezolid
KW - co-resistance
KW - antimicrobial
KW - antibacterial
KW - antibiotic
KW - IncX4::mcr-1
KW - IncF::Tn1441d- blaKPC-3
KW - Escherichia coli ST744
KW - Klebsiella pneumoniae
KW - multiresistance
KW - Portugal
KW - gene, carbapenem, meropenem, colistin, polymixin, fluconazole, linezolid, co-resistance, antimicrobial resistance, antibacterial, antibiotic
KW - IncX4::mcr-1, IncF::Tn1441d- blaKPC-3, sequence type, Escherichia coli ST744, Klebsiella pneumoniae, multiresistance, Portugal, bacteria
DO - 10.3201/eid2308.170162
UR - https://wwwnc.cdc.gov/eid/article/23/8/17-0162_article
ER - End of Reference